Management of checkpoint inhibitor-associated renal toxicities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of checkpoint inhibitor-associated renal toxicities

Published:2017-07-04 Issue:4 Volume:2 Page:215-223
ISSN:2380-9000
Container-title:Expert Review of Quality of Life in Cancer Care
language:en
Short-container-title:Expert Review of Quality of Life in Cancer Care

Author:

Vanoverbeke Lowie¹,Sprangers Ben²³⁴

Affiliation:

1. Department of Internal Medicine, University Hospitals Leuven, Leuven, Belgium

2. Department of Microbiology and Immunology, Laboratory of Experimental Transplantation, University Hospitals Leuven, Leuven, Belgium

3. Department of Nephrology, University Hospitals Leuven, Leuven, Belgium

4. Cancer-Kidney International Network (C-KIN), Brussels, Belgium

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/23809000.2017.1369045

Reference67 articles.

1. On being less tolerant: Enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation

2. The future of immune checkpoint therapy

3. Releasing the Brakes on Cancer Immunotherapy

4. Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper

5. Immune-related adverse events with immune checkpoint blockade: a comprehensive review

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pembrolizumab-induced focal segmental glomerulosclerosis;Medicine;2021-10-29

2. Filtering Data About Treatment-Induced Renal Injury: From Biology to Practice;Journal of Thoracic Oncology;2020-09

3. Renal immune‐related adverse events of immune checkpoint inhibitor;Asia-Pacific Journal of Clinical Oncology;2020-06-23

4. Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents;Safety and Risk of Pharmacotherapy;2020-03-26

5. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance;Nature Reviews Clinical Oncology;2019-05-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3